EUVIMEDEUVIMED entdecken
Crossref

Identification of Or5v1/Olfr110 as an oxylipin receptor and anti-obesity target

Xiao-Yan Ge, Jie Cheng, Li-Jun Zhang, Lu-Lu Guo, Rui Xiang, Yan Lu, Shang-Lei Ning, Kai-Yu Wang, Kong-Kai Zhu, Ming-Xin Gao, Yue Li, Yu-Song Zhang und 13 weitere

Cell · 2026-03 · 189 (5) · 1481-1498.e22

DOI: 10.1016/j.cell.2025.12.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2026-03. Verfasst von Xiao-Yan Ge und 24 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Medical Research Institute, NHC Key Laboratory of Otorhinolaryngology, Qi lu Hospital, New Cornerstone Science Laboratory, Cheeloo College o…. Hauptthemen laut MEDLINE: Obesity, Receptors, Odorant, Oxylipins, Anti-Obesity Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Key Technologies Research and Development Program, National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxylipins are important metabolic messengers for normal life activities, and olfactory receptors (ORs) are known for their low affinity for odor and are not considered oxylipin receptors. By developing the "anonymous receptor identification by reverse-G-protein pull-down" (ARIG) method, we identify orphan OR Or5v1/Olfr110 as an oxylipin 12(S)-hydroxyeicosapentaenoic acid (12(S)-HEPE) receptor. The serum from obese patients with increased BMI showed lower Or5v1/Olfr110-Gs activation compared with normal people. Systemic Or5v1/Olfr110 deficiency or liver-specific Or5v1/Olfr110 deficiency impaired glucose homeostasis, even after stimulation with 12(S)-HEPE. Engagement of 12(S)-HEPE with Olfr110 activated Gs-PKA-pATF2-Cpt1α signaling to reduce obesity through promotion of fatty acid oxidation in liver. Structural aided development of synthetic agonist HOR1-C59 improved glucose homeostasis, which is dependent on Or5v1/Olfr110 expression. Overall, we revealed that a high-affinity oxylipin-sensing OR plays key roles in metabolism. The beneficial effects of HOR1-C59 underscore the therapeutic value of small synthetic compounds that target ORs for disease treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityReceptors, OdorantOxylipinsAnti-Obesity AgentsHumansAnimalsLiverMiceSignal TransductionGlucoseMice, Inbred C57BLMaleHEK293 Cells

Stichwörter der Autor:innen

GPCR signal transductiondrug developmentobesityolfactory receptor

Substanzen

Receptors, OdorantOxylipinsAnti-Obesity AgentsGlucose

Autor:innen und Institutionen

  • Advanced Medical Research Institute, NHC Key Laboratory of Otorhinolaryngology, Qi lu Hospital, New Cornerstone Science Laboratory, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
  • Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Shandong Key Laboratory of Mental Disorders and Intelligent Control, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
  • Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Beijing Key Laboratory of Cardiovascular Receptors Research, Peking University…
  • Department of Hepatobiliary Surgery, General Surgery, Qilu Hospital, Gheeloo College of Medicine, Shandong University, Jinan 250012, China.
  • Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
  • School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.

Förderung

  • Key Technologies Research and Development Program
  • National Science Fund for Distinguished Young Scholars
  • National Natural Science Foundation of China
  • National Major Science and Technology Projects of China
  • Tai'shan Scholar Engineering Construction Fund of Shandong Province of China

Zitieren

APA

Ge, X. Y., Cheng, J., Zhang, L. J., Guo, L. L., Xiang, R., Lu, Y., Ning, S. L., Wang, K. Y., Zhu, K. K., Gao, M. X., Li, Y., Zhang, Y. S., Rong, N. K., Han, X., Zhang, M. H., Fang, L., Xu, Y. F., Zhao, S. W., Li, Q., …, & Sun, J. P. (2026). Identification of Or5v1/Olfr110 as an oxylipin receptor and anti-obesity target. Cell, 189(5), 1481-1498.e22. https://doi.org/10.1016/j.cell.2025.12.016

Vancouver

Ge XY, Cheng J, Zhang LJ, Guo LL, Xiang R, Lu Y, et al. Identification of Or5v1/Olfr110 as an oxylipin receptor and anti-obesity target. Cell. 2026;189(5):1481-1498.e22. doi:10.1016/j.cell.2025.12.016

BibTeX
@article{Ge2026,
  author = {Ge, Xiao-Yan and Cheng, Jie and Zhang, Li-Jun and Guo, Lu-Lu and Xiang, Rui and Lu, Yan and Ning, Shang-Lei and Wang, Kai-Yu and Zhu, Kong-Kai and Gao, Ming-Xin and Li, Yue and Zhang, Yu-Song and Rong, Nai-Kang and Han, Xiang and Zhang, Ming-Hui and Fang, Le and Xu, Yun-Fei and Zhao, Su-Wen and Li, Qian and Yang, Fan and Hao, Yong and Chai, Ren-Jie and Yu, Xiao and Yang, Ji-Chun and Sun, Jin-Peng},
  title = {Identification of Or5v1/Olfr110 as an oxylipin receptor and anti-obesity target},
  journal = {Cell},
  year = {2026},
  volume = {189},
  number = {5},
  pages = {1481--1498.e22},
  doi = {10.1016/j.cell.2025.12.016}
}
Kostenlos starten →